Amylyx Pharmaceuticals, Inc. (AMLX)
Nasdaq: AMLX · CIK 0001658551 · United States
Every official Amylyx Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AMLX filings
Amylyx Pharmaceuticals, Inc. documents
- Amylyx Pharmaceuticals, Inc. 10-K 2026AMLX 10-K 2026: annual report for fiscal 2026
- Amylyx Pharmaceuticals, Inc. 10-K 2025AMLX 10-K 2025: annual report for fiscal 2025
- Amylyx Pharmaceuticals, Inc. 10-K 2024AMLX 10-K 2024: annual report for fiscal 2024
- Amylyx Pharmaceuticals, Inc. 10-K 2023AMLX 10-K 2023: annual report for fiscal 2023
- Amylyx Pharmaceuticals, Inc. 10-K 2022AMLX 10-K 2022: annual report for fiscal 2022
- Amylyx Pharmaceuticals, Inc. 10-Q 2026AMLX 10-Q 2026: quarterly report for fiscal 2026
- Amylyx Pharmaceuticals, Inc. 10-Q 2025AMLX 10-Q 2025: quarterly report for fiscal 2025
- Amylyx Pharmaceuticals, Inc. 10-Q 2024AMLX 10-Q 2024: quarterly report for fiscal 2024
- Amylyx Pharmaceuticals, Inc. 10-Q 2023AMLX 10-Q 2023: quarterly report for fiscal 2023
- Amylyx Pharmaceuticals, Inc. 10-Q 2022AMLX 10-Q 2022: quarterly report for fiscal 2022
- Amylyx Pharmaceuticals, Inc. 8-K 2026AMLX 8-K 2026: current report for fiscal 2026
- Amylyx Pharmaceuticals, Inc. 8-K 2025AMLX 8-K 2025: current report for fiscal 2025
- Amylyx Pharmaceuticals, Inc. 8-K 2024AMLX 8-K 2024: current report for fiscal 2024
- Amylyx Pharmaceuticals, Inc. 8-K 2023AMLX 8-K 2023: current report for fiscal 2023
- Amylyx Pharmaceuticals, Inc. 8-K 2022AMLX 8-K 2022: current report for fiscal 2022
- Amylyx Pharmaceuticals, Inc. DEF 14A 2026AMLX DEF 14A 2026: proxy statement for fiscal 2026
- Amylyx Pharmaceuticals, Inc. DEF 14A 2025AMLX DEF 14A 2025: proxy statement for fiscal 2025
- Amylyx Pharmaceuticals, Inc. DEF 14A 2024AMLX DEF 14A 2024: proxy statement for fiscal 2024
- Amylyx Pharmaceuticals, Inc. DEF 14A 2023AMLX DEF 14A 2023: proxy statement for fiscal 2023
- Amylyx Pharmaceuticals, Inc. DEF 14A 2022AMLX DEF 14A 2022: proxy statement for fiscal 2022
- Amylyx Pharmaceuticals, Inc. Form 4 2026AMLX Form 4 2026: insider trading filing for fiscal 2026
- Amylyx Pharmaceuticals, Inc. Form 4 2025AMLX Form 4 2025: insider trading filing for fiscal 2025
- Amylyx Pharmaceuticals, Inc. Form 4 2024AMLX Form 4 2024: insider trading filing for fiscal 2024
- Amylyx Pharmaceuticals, Inc. Form 4 2023AMLX Form 4 2023: insider trading filing for fiscal 2023
- Amylyx Pharmaceuticals, Inc. Form 4 2022AMLX Form 4 2022: insider trading filing for fiscal 2022
- Amylyx Pharmaceuticals, Inc. S-1 2026AMLX S-1 2026: registration statement for fiscal 2026
- Amylyx Pharmaceuticals, Inc. S-1 2025AMLX S-1 2025: registration statement for fiscal 2025
- Amylyx Pharmaceuticals, Inc. S-1 2024AMLX S-1 2024: registration statement for fiscal 2024
- Amylyx Pharmaceuticals, Inc. S-1 2023AMLX S-1 2023: registration statement for fiscal 2023
- Amylyx Pharmaceuticals, Inc. S-1 2022AMLX S-1 2022: registration statement for fiscal 2022
- Amylyx Pharmaceuticals, Inc. 13F 2026AMLX 13F 2026: institutional holdings for fiscal 2026
- Amylyx Pharmaceuticals, Inc. 13F 2025AMLX 13F 2025: institutional holdings for fiscal 2025
- Amylyx Pharmaceuticals, Inc. 13F 2024AMLX 13F 2024: institutional holdings for fiscal 2024
- Amylyx Pharmaceuticals, Inc. 13F 2023AMLX 13F 2023: institutional holdings for fiscal 2023
- Amylyx Pharmaceuticals, Inc. 13F 2022AMLX 13F 2022: institutional holdings for fiscal 2022
More companies